Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Meningeal Neoplasms | 32 | 2023 | 1241 | 5.550 |
Why?
|
Meningioma | 32 | 2023 | 1209 | 5.350 |
Why?
|
Craniopharyngioma | 12 | 2024 | 281 | 3.450 |
Why?
|
Pituitary Neoplasms | 18 | 2024 | 1346 | 2.770 |
Why?
|
Homeodomain Proteins | 15 | 2021 | 2422 | 1.680 |
Why?
|
Brain Neoplasms | 39 | 2023 | 8860 | 1.630 |
Why?
|
Proto-Oncogene Proteins B-raf | 12 | 2024 | 2041 | 1.550 |
Why?
|
Glioma | 20 | 2023 | 3401 | 1.350 |
Why?
|
Rhabdoid Tumor | 2 | 2024 | 212 | 1.330 |
Why?
|
Fluorescent Antibody Technique | 5 | 2023 | 2505 | 1.210 |
Why?
|
Ubiquitin Thiolesterase | 5 | 2023 | 449 | 1.180 |
Why?
|
Cerebellar Neoplasms | 5 | 2024 | 587 | 1.130 |
Why?
|
Transcription Factors | 18 | 2021 | 12207 | 1.100 |
Why?
|
Central Nervous System Neoplasms | 4 | 2024 | 895 | 1.070 |
Why?
|
Glioblastoma | 10 | 2024 | 3481 | 1.060 |
Why?
|
Pineal Gland | 3 | 2018 | 166 | 0.930 |
Why?
|
Heat-Shock Proteins | 3 | 2020 | 822 | 0.910 |
Why?
|
DNA-Binding Proteins | 24 | 2020 | 9647 | 0.910 |
Why?
|
Astrocytoma | 6 | 2014 | 789 | 0.820 |
Why?
|
Cilia | 2 | 2016 | 466 | 0.810 |
Why?
|
Tumor Microenvironment | 15 | 2024 | 3584 | 0.780 |
Why?
|
Mutation | 42 | 2024 | 29784 | 0.770 |
Why?
|
Forkhead Transcription Factors | 3 | 2017 | 1613 | 0.770 |
Why?
|
Pinealoma | 2 | 2018 | 54 | 0.760 |
Why?
|
Tumor Suppressor Proteins | 6 | 2020 | 2848 | 0.710 |
Why?
|
Neoplasms | 22 | 2023 | 21672 | 0.690 |
Why?
|
Immunoconjugates | 2 | 2024 | 901 | 0.680 |
Why?
|
Palatine Tonsil | 1 | 2019 | 193 | 0.680 |
Why?
|
Central Nervous System Cysts | 2 | 2016 | 58 | 0.670 |
Why?
|
Medulloblastoma | 6 | 2019 | 683 | 0.660 |
Why?
|
Heat-Shock Response | 3 | 2020 | 165 | 0.660 |
Why?
|
Skull Base Neoplasms | 1 | 2021 | 284 | 0.620 |
Why?
|
Glutarates | 2 | 2022 | 236 | 0.620 |
Why?
|
Gastrointestinal Stromal Tumors | 2 | 2021 | 643 | 0.620 |
Why?
|
Neoplasm Recurrence, Local | 15 | 2023 | 9230 | 0.620 |
Why?
|
Single-Cell Analysis | 6 | 2022 | 2183 | 0.600 |
Why?
|
Genomics | 14 | 2024 | 5722 | 0.590 |
Why?
|
Gene Expression Regulation, Neoplastic | 15 | 2021 | 8426 | 0.580 |
Why?
|
Choroid Plexus Neoplasms | 1 | 2016 | 43 | 0.550 |
Why?
|
Breast Neoplasms | 13 | 2024 | 20817 | 0.550 |
Why?
|
Gastrointestinal Neoplasms | 2 | 2021 | 989 | 0.540 |
Why?
|
Humans | 180 | 2024 | 744220 | 0.530 |
Why?
|
Trans-Activators | 3 | 2017 | 2924 | 0.530 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 2 | 2021 | 1114 | 0.530 |
Why?
|
Neurofibromatosis 2 | 1 | 2019 | 380 | 0.530 |
Why?
|
Axonemal Dyneins | 1 | 2014 | 24 | 0.510 |
Why?
|
Genes, RAG-1 | 6 | 2001 | 68 | 0.500 |
Why?
|
Central Nervous System Diseases | 1 | 2019 | 518 | 0.500 |
Why?
|
Comparative Genomic Hybridization | 9 | 2017 | 496 | 0.500 |
Why?
|
Xanthomatosis | 1 | 2014 | 32 | 0.500 |
Why?
|
Cell Nucleus | 7 | 2022 | 2969 | 0.490 |
Why?
|
Recombination, Genetic | 8 | 2001 | 1586 | 0.490 |
Why?
|
Lung Neoplasms | 8 | 2024 | 13096 | 0.490 |
Why?
|
Biology | 1 | 2016 | 294 | 0.490 |
Why?
|
Cell Lineage | 4 | 2019 | 2504 | 0.480 |
Why?
|
Germinoma | 2 | 2022 | 133 | 0.480 |
Why?
|
Mass Spectrometry | 4 | 2019 | 2204 | 0.470 |
Why?
|
Antineoplastic Agents | 13 | 2023 | 13668 | 0.470 |
Why?
|
Brain Edema | 1 | 2018 | 617 | 0.470 |
Why?
|
Telomerase | 4 | 2020 | 729 | 0.450 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2014 | 403 | 0.450 |
Why?
|
Adaptation, Physiological | 1 | 2020 | 1312 | 0.440 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 5 | 2015 | 276 | 0.440 |
Why?
|
Stromal Cells | 1 | 2018 | 1355 | 0.430 |
Why?
|
Ependymoma | 1 | 2016 | 334 | 0.430 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 5 | 2023 | 503 | 0.430 |
Why?
|
Antibodies | 2 | 2019 | 2461 | 0.420 |
Why?
|
Immunotherapy | 5 | 2023 | 4440 | 0.420 |
Why?
|
Protein Biosynthesis | 2 | 2013 | 2126 | 0.410 |
Why?
|
DNA Nucleotidyltransferases | 3 | 2001 | 193 | 0.410 |
Why?
|
Patient Care | 1 | 2017 | 640 | 0.400 |
Why?
|
Nervous System Diseases | 1 | 2021 | 1623 | 0.390 |
Why?
|
Point Mutation | 2 | 2015 | 1624 | 0.380 |
Why?
|
Intraoperative Care | 1 | 2014 | 767 | 0.370 |
Why?
|
Carcinoma, Papillary | 1 | 2015 | 783 | 0.370 |
Why?
|
Image Processing, Computer-Assisted | 6 | 2023 | 8950 | 0.370 |
Why?
|
DNA Copy Number Variations | 7 | 2020 | 1940 | 0.360 |
Why?
|
Computer Graphics | 2 | 2022 | 360 | 0.360 |
Why?
|
Cell Line, Tumor | 19 | 2023 | 16687 | 0.360 |
Why?
|
Ribosomes | 1 | 2013 | 500 | 0.360 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 2 | 2022 | 484 | 0.350 |
Why?
|
HSP90 Heat-Shock Proteins | 4 | 2019 | 434 | 0.350 |
Why?
|
CD8-Positive T-Lymphocytes | 7 | 2023 | 4477 | 0.350 |
Why?
|
Paraffin Embedding | 3 | 2019 | 299 | 0.350 |
Why?
|
Nuclear Proteins | 12 | 2018 | 5853 | 0.340 |
Why?
|
Epitopes | 2 | 2021 | 2571 | 0.340 |
Why?
|
Spinal Cord Neoplasms | 2 | 2014 | 281 | 0.340 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2015 | 1039 | 0.340 |
Why?
|
Formaldehyde | 3 | 2019 | 353 | 0.340 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2011 | 731 | 0.330 |
Why?
|
Cell Cycle | 4 | 2022 | 2967 | 0.320 |
Why?
|
Chromosome Aberrations | 1 | 2014 | 1814 | 0.310 |
Why?
|
Retinal Neoplasms | 1 | 2009 | 144 | 0.310 |
Why?
|
Breast | 3 | 2022 | 1969 | 0.300 |
Why?
|
Immunohistochemistry | 10 | 2019 | 11368 | 0.290 |
Why?
|
Molecular Chaperones | 4 | 2020 | 742 | 0.290 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2016 | 2938 | 0.290 |
Why?
|
Leiomyosarcoma | 2 | 2024 | 477 | 0.290 |
Why?
|
Immunologic Deficiency Syndromes | 2 | 2000 | 547 | 0.290 |
Why?
|
DNA Mutational Analysis | 7 | 2020 | 4188 | 0.290 |
Why?
|
Mice | 31 | 2024 | 81178 | 0.280 |
Why?
|
Adenoma | 4 | 2020 | 2174 | 0.280 |
Why?
|
Indoles | 1 | 2014 | 1838 | 0.270 |
Why?
|
Prognosis | 15 | 2023 | 29050 | 0.270 |
Why?
|
Epithelial Cells | 2 | 2015 | 3690 | 0.270 |
Why?
|
Cell Proliferation | 7 | 2022 | 10480 | 0.270 |
Why?
|
Solitary Fibrous Tumors | 2 | 2023 | 72 | 0.260 |
Why?
|
Neuroma | 1 | 2006 | 103 | 0.260 |
Why?
|
Software | 5 | 2022 | 4442 | 0.260 |
Why?
|
Valine | 3 | 2015 | 413 | 0.250 |
Why?
|
Proteins | 7 | 2020 | 6101 | 0.250 |
Why?
|
Sulfonamides | 1 | 2014 | 1940 | 0.250 |
Why?
|
Animals | 44 | 2024 | 168788 | 0.250 |
Why?
|
Histones | 4 | 2023 | 2600 | 0.240 |
Why?
|
Tumor Cells, Cultured | 4 | 2021 | 6313 | 0.240 |
Why?
|
Severe Combined Immunodeficiency | 4 | 2001 | 223 | 0.240 |
Why?
|
Vestibular Diseases | 1 | 2006 | 217 | 0.240 |
Why?
|
Tissue Array Analysis | 2 | 2018 | 553 | 0.230 |
Why?
|
Molecular Sequence Data | 13 | 2015 | 18116 | 0.230 |
Why?
|
Molecular Imaging | 3 | 2016 | 831 | 0.230 |
Why?
|
Claudins | 1 | 2024 | 111 | 0.230 |
Why?
|
Disease Progression | 8 | 2023 | 13280 | 0.220 |
Why?
|
Proto-Oncogene Proteins c-akt | 6 | 2021 | 2503 | 0.220 |
Why?
|
Survival Rate | 7 | 2021 | 12781 | 0.220 |
Why?
|
Furans | 1 | 2024 | 194 | 0.220 |
Why?
|
Ketones | 1 | 2024 | 188 | 0.220 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2007 | 546 | 0.220 |
Why?
|
Isocitrate Dehydrogenase | 4 | 2022 | 871 | 0.220 |
Why?
|
Spectrum Analysis, Raman | 2 | 2016 | 247 | 0.220 |
Why?
|
Female | 52 | 2024 | 380197 | 0.210 |
Why?
|
Choriocarcinoma | 1 | 2022 | 123 | 0.210 |
Why?
|
T-Lymphocytes | 3 | 2018 | 10182 | 0.210 |
Why?
|
Hemangiosarcoma | 1 | 2024 | 239 | 0.200 |
Why?
|
Circadian Clocks | 1 | 2024 | 171 | 0.200 |
Why?
|
Sarcoidosis | 1 | 2007 | 505 | 0.200 |
Why?
|
Neurofibromin 2 | 5 | 2023 | 267 | 0.200 |
Why?
|
Cyclin-Dependent Kinase 6 | 2 | 2021 | 322 | 0.200 |
Why?
|
Molecular Targeted Therapy | 5 | 2021 | 2727 | 0.200 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2020 | 2942 | 0.200 |
Why?
|
5'-Nucleotidase | 1 | 2022 | 160 | 0.200 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2015 | 2988 | 0.200 |
Why?
|
Apoptosis | 6 | 2023 | 9728 | 0.200 |
Why?
|
Oncogenes | 4 | 2023 | 1265 | 0.200 |
Why?
|
Receptors, CCR | 1 | 2021 | 38 | 0.200 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2021 | 147 | 0.190 |
Why?
|
Glutamic Acid | 3 | 2015 | 1169 | 0.190 |
Why?
|
Neurilemmoma | 1 | 2006 | 547 | 0.190 |
Why?
|
Heterotrimeric GTP-Binding Proteins | 1 | 2001 | 93 | 0.190 |
Why?
|
Phosphatidylinositol 4,5-Diphosphate | 1 | 2001 | 127 | 0.190 |
Why?
|
Liposarcoma | 1 | 2024 | 333 | 0.190 |
Why?
|
Citric Acid Cycle | 1 | 2022 | 232 | 0.190 |
Why?
|
Isoenzymes | 2 | 2006 | 1726 | 0.190 |
Why?
|
Ecosystem | 2 | 2022 | 474 | 0.190 |
Why?
|
Xenograft Model Antitumor Assays | 5 | 2021 | 3557 | 0.190 |
Why?
|
Type C Phospholipases | 1 | 2001 | 292 | 0.190 |
Why?
|
Male | 49 | 2023 | 350027 | 0.190 |
Why?
|
Proteomics | 4 | 2024 | 3637 | 0.180 |
Why?
|
Base Sequence | 8 | 2014 | 12801 | 0.180 |
Why?
|
Cell Differentiation | 5 | 2020 | 11478 | 0.180 |
Why?
|
High-Throughput Nucleotide Sequencing | 7 | 2022 | 3598 | 0.180 |
Why?
|
Phase Transition | 1 | 2020 | 74 | 0.180 |
Why?
|
Germ-Line Mutation | 2 | 2018 | 1787 | 0.180 |
Why?
|
Radiotherapy | 1 | 2007 | 1525 | 0.180 |
Why?
|
Diagnostic Imaging | 5 | 2023 | 3508 | 0.180 |
Why?
|
Pharmaceutical Preparations | 2 | 2022 | 1071 | 0.180 |
Why?
|
Proteasome Endopeptidase Complex | 2 | 2016 | 1337 | 0.180 |
Why?
|
Ovarian Neoplasms | 3 | 2022 | 4837 | 0.170 |
Why?
|
Middle Aged | 31 | 2023 | 213367 | 0.170 |
Why?
|
Copper | 1 | 2022 | 366 | 0.170 |
Why?
|
Co-Repressor Proteins | 1 | 2020 | 194 | 0.170 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 3 | 2021 | 890 | 0.170 |
Why?
|
Gene Expression Profiling | 9 | 2023 | 9438 | 0.170 |
Why?
|
Child | 17 | 2024 | 77679 | 0.170 |
Why?
|
Protein Kinase Inhibitors | 5 | 2020 | 5529 | 0.170 |
Why?
|
Clone Cells | 1 | 2022 | 1692 | 0.170 |
Why?
|
Frameshift Mutation | 1 | 2000 | 399 | 0.170 |
Why?
|
Receptors, Prostaglandin | 1 | 2018 | 57 | 0.170 |
Why?
|
Retina | 1 | 2009 | 2616 | 0.160 |
Why?
|
Tissue Fixation | 1 | 2019 | 241 | 0.160 |
Why?
|
Intercellular Signaling Peptides and Proteins | 4 | 2017 | 1676 | 0.160 |
Why?
|
Hemangiopericytoma | 1 | 2018 | 77 | 0.160 |
Why?
|
Young Adult | 14 | 2023 | 56436 | 0.160 |
Why?
|
Antigens, Neoplasm | 3 | 2021 | 1987 | 0.160 |
Why?
|
Signal Transduction | 7 | 2021 | 23404 | 0.160 |
Why?
|
Methionine | 1 | 2000 | 590 | 0.160 |
Why?
|
Monitoring, Intraoperative | 2 | 2016 | 953 | 0.160 |
Why?
|
Disease Management | 3 | 2018 | 2458 | 0.160 |
Why?
|
BRCA1 Protein | 2 | 2022 | 1149 | 0.160 |
Why?
|
Magnetic Resonance Imaging | 11 | 2018 | 35423 | 0.160 |
Why?
|
Oligodendroglioma | 3 | 2014 | 279 | 0.160 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2022 | 450 | 0.160 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 5 | 2020 | 11493 | 0.150 |
Why?
|
Adult | 29 | 2023 | 214035 | 0.150 |
Why?
|
Colonic Neoplasms | 2 | 2020 | 2538 | 0.150 |
Why?
|
Gene Dosage | 3 | 2017 | 1251 | 0.150 |
Why?
|
Microscopy | 3 | 2022 | 903 | 0.150 |
Why?
|
Antibodies, Monoclonal | 1 | 2014 | 9275 | 0.150 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 4752 | 0.150 |
Why?
|
Adenosine | 1 | 2022 | 825 | 0.150 |
Why?
|
Withanolides | 2 | 2014 | 12 | 0.150 |
Why?
|
HMGB Proteins | 2 | 2007 | 45 | 0.150 |
Why?
|
Dystrophin | 1 | 2018 | 285 | 0.150 |
Why?
|
Obesity | 2 | 2018 | 12742 | 0.150 |
Why?
|
Azepines | 1 | 2019 | 336 | 0.150 |
Why?
|
Receptors, Leptin | 1 | 2018 | 360 | 0.140 |
Why?
|
BRCA2 Protein | 1 | 2022 | 794 | 0.140 |
Why?
|
Immunity | 1 | 2023 | 1012 | 0.140 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2021 | 601 | 0.140 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 3 | 2024 | 647 | 0.140 |
Why?
|
Ependyma | 1 | 2016 | 54 | 0.140 |
Why?
|
Oncogene Proteins v-myb | 1 | 2016 | 26 | 0.140 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2018 | 473 | 0.140 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2018 | 241 | 0.140 |
Why?
|
Endocrine Gland Neoplasms | 1 | 2015 | 25 | 0.140 |
Why?
|
Octamer Transcription Factor-3 | 2 | 2007 | 223 | 0.140 |
Why?
|
Progestins | 1 | 2018 | 306 | 0.140 |
Why?
|
Intracellular Signaling Peptides and Proteins | 4 | 2023 | 2916 | 0.130 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2016 | 1581 | 0.130 |
Why?
|
Follow-Up Studies | 6 | 2021 | 39045 | 0.130 |
Why?
|
Neoplasm Metastasis | 3 | 2020 | 4841 | 0.130 |
Why?
|
Gene Rearrangement | 2 | 2016 | 1179 | 0.130 |
Why?
|
Pituitary Gland | 2 | 2015 | 665 | 0.130 |
Why?
|
Orbital Neoplasms | 1 | 2017 | 225 | 0.130 |
Why?
|
Diagnosis, Differential | 8 | 2018 | 12961 | 0.130 |
Why?
|
Neoplasm Transplantation | 3 | 2014 | 2085 | 0.130 |
Why?
|
SOXB1 Transcription Factors | 2 | 2007 | 284 | 0.130 |
Why?
|
Arginine Vasopressin | 1 | 2015 | 130 | 0.130 |
Why?
|
Survival Analysis | 4 | 2021 | 10250 | 0.130 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2022 | 949 | 0.130 |
Why?
|
RNA, Messenger | 6 | 2018 | 13036 | 0.130 |
Why?
|
Neoplasm Proteins | 3 | 2018 | 3703 | 0.130 |
Why?
|
Adenosine Triphosphatases | 1 | 1999 | 839 | 0.130 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2023 | 1634 | 0.130 |
Why?
|
Adolescent | 15 | 2023 | 85759 | 0.130 |
Why?
|
Cell Survival | 3 | 2020 | 5881 | 0.120 |
Why?
|
NF-kappa B | 1 | 2023 | 2501 | 0.120 |
Why?
|
NIH 3T3 Cells | 2 | 2013 | 677 | 0.120 |
Why?
|
Drug Administration Schedule | 4 | 2019 | 4929 | 0.120 |
Why?
|
Neoplasm Staging | 4 | 2018 | 11007 | 0.120 |
Why?
|
Amino Acid Sequence | 8 | 2021 | 13817 | 0.120 |
Why?
|
Melanoma | 2 | 2024 | 5475 | 0.120 |
Why?
|
Pancreatic Neoplasms | 2 | 2023 | 5257 | 0.120 |
Why?
|
Chromosomes, Human | 1 | 2016 | 457 | 0.120 |
Why?
|
Hemangioblastoma | 1 | 2014 | 70 | 0.120 |
Why?
|
Poxviridae Infections | 1 | 2014 | 12 | 0.120 |
Why?
|
Quinolines | 1 | 2019 | 730 | 0.120 |
Why?
|
Orthopoxvirus | 1 | 2014 | 11 | 0.120 |
Why?
|
Phenotype | 6 | 2021 | 16365 | 0.120 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2021 | 5169 | 0.120 |
Why?
|
Semantics | 1 | 2017 | 584 | 0.120 |
Why?
|
Soft Tissue Neoplasms | 1 | 2023 | 1363 | 0.120 |
Why?
|
Telomere | 1 | 2020 | 910 | 0.120 |
Why?
|
Sequence Analysis, DNA | 5 | 2020 | 4803 | 0.120 |
Why?
|
RNA | 1 | 2024 | 2749 | 0.120 |
Why?
|
Neuronavigation | 1 | 2015 | 167 | 0.120 |
Why?
|
Gene Deletion | 2 | 2018 | 2751 | 0.120 |
Why?
|
Computer Systems | 1 | 2015 | 483 | 0.120 |
Why?
|
Fatal Outcome | 1 | 2018 | 1849 | 0.120 |
Why?
|
Small Molecule Libraries | 1 | 2019 | 720 | 0.110 |
Why?
|
Triazoles | 1 | 2019 | 911 | 0.110 |
Why?
|
In Situ Hybridization, Fluorescence | 4 | 2015 | 2649 | 0.110 |
Why?
|
Intermediate Filaments | 1 | 2014 | 175 | 0.110 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2024 | 5221 | 0.110 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2015 | 648 | 0.110 |
Why?
|
Encephalomyelitis, Eastern Equine | 1 | 2013 | 15 | 0.110 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2014 | 290 | 0.110 |
Why?
|
Gene Targeting | 1 | 2016 | 880 | 0.110 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2015 | 628 | 0.110 |
Why?
|
Protein Structure, Tertiary | 5 | 2013 | 3846 | 0.110 |
Why?
|
Benzofurans | 1 | 2013 | 140 | 0.110 |
Why?
|
Cross Reactions | 1 | 2014 | 841 | 0.110 |
Why?
|
Genotype | 8 | 2022 | 12956 | 0.110 |
Why?
|
Breast Neoplasms, Male | 1 | 2014 | 210 | 0.110 |
Why?
|
Histocytochemistry | 1 | 2013 | 719 | 0.110 |
Why?
|
Neurogenesis | 1 | 2019 | 838 | 0.110 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2020 | 1692 | 0.110 |
Why?
|
Aged | 21 | 2023 | 163253 | 0.110 |
Why?
|
Sarcoma | 1 | 2024 | 1897 | 0.110 |
Why?
|
Genes, Neurofibromatosis 1 | 1 | 2012 | 79 | 0.110 |
Why?
|
Lipids | 3 | 2014 | 3305 | 0.110 |
Why?
|
beta Catenin | 2 | 2016 | 1059 | 0.110 |
Why?
|
Promoter Regions, Genetic | 4 | 2020 | 5867 | 0.110 |
Why?
|
Receptors, Immunologic | 1 | 2018 | 1423 | 0.100 |
Why?
|
DNA | 4 | 2001 | 7303 | 0.100 |
Why?
|
Awards and Prizes | 1 | 2016 | 375 | 0.100 |
Why?
|
DNA Fragmentation | 1 | 2012 | 242 | 0.100 |
Why?
|
Host-Parasite Interactions | 1 | 2014 | 295 | 0.100 |
Why?
|
Immunoenzyme Techniques | 1 | 2015 | 1799 | 0.100 |
Why?
|
Bayes Theorem | 2 | 2023 | 2309 | 0.100 |
Why?
|
Receptors, Calcitriol | 1 | 2014 | 350 | 0.100 |
Why?
|
Drug Eruptions | 1 | 2014 | 297 | 0.100 |
Why?
|
Algorithms | 5 | 2022 | 13885 | 0.100 |
Why?
|
Embryonic Stem Cells | 2 | 2010 | 1294 | 0.100 |
Why?
|
Cohort Studies | 8 | 2022 | 40559 | 0.100 |
Why?
|
Sclerosis | 1 | 2011 | 213 | 0.100 |
Why?
|
Neurofibromin 1 | 1 | 2012 | 196 | 0.100 |
Why?
|
Myelin P0 Protein | 1 | 2010 | 15 | 0.100 |
Why?
|
Frozen Sections | 1 | 2011 | 155 | 0.100 |
Why?
|
Blood-Brain Barrier | 2 | 2016 | 1016 | 0.100 |
Why?
|
Nucleic Acid Denaturation | 1 | 2011 | 111 | 0.100 |
Why?
|
MAP Kinase Signaling System | 2 | 2015 | 1525 | 0.100 |
Why?
|
Antineoplastic Agents, Alkylating | 2 | 2020 | 627 | 0.100 |
Why?
|
Microscopy, Fluorescence | 1 | 2018 | 2700 | 0.100 |
Why?
|
Aged, 80 and over | 11 | 2020 | 57768 | 0.090 |
Why?
|
VDJ Recombinases | 2 | 2000 | 84 | 0.090 |
Why?
|
Sural Nerve | 1 | 2010 | 112 | 0.090 |
Why?
|
History, 21st Century | 1 | 2016 | 1534 | 0.090 |
Why?
|
Leptin | 1 | 2018 | 1599 | 0.090 |
Why?
|
Cell Line | 7 | 2020 | 15999 | 0.090 |
Why?
|
Oxidants | 1 | 2010 | 164 | 0.090 |
Why?
|
Mitochondria | 2 | 2022 | 3520 | 0.090 |
Why?
|
Repressor Proteins | 2 | 2018 | 3023 | 0.090 |
Why?
|
Gene Rearrangement, T-Lymphocyte | 2 | 2000 | 113 | 0.090 |
Why?
|
Cysteine | 1 | 2014 | 874 | 0.090 |
Why?
|
Genetic Association Studies | 1 | 2018 | 2702 | 0.080 |
Why?
|
Demyelinating Diseases | 1 | 2011 | 363 | 0.080 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2014 | 1770 | 0.080 |
Why?
|
History, 20th Century | 1 | 2016 | 2739 | 0.080 |
Why?
|
Clinical Trials as Topic | 3 | 2022 | 7908 | 0.080 |
Why?
|
Exons | 1 | 2014 | 2439 | 0.080 |
Why?
|
Hepatocytes | 1 | 2015 | 1210 | 0.080 |
Why?
|
Chromosomes, Human, X | 1 | 2010 | 296 | 0.080 |
Why?
|
Drug Interactions | 1 | 2013 | 1458 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 3 | 2019 | 17449 | 0.080 |
Why?
|
Uterine Neoplasms | 1 | 2017 | 1513 | 0.080 |
Why?
|
Treatment Outcome | 9 | 2024 | 63119 | 0.080 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 625 | 0.080 |
Why?
|
Stem Cells | 1 | 2021 | 3567 | 0.080 |
Why?
|
X Chromosome Inactivation | 1 | 2010 | 224 | 0.080 |
Why?
|
Adenocarcinoma | 2 | 2023 | 6352 | 0.080 |
Why?
|
Phosphorylation | 3 | 2012 | 8437 | 0.080 |
Why?
|
Peptide Library | 1 | 2009 | 349 | 0.080 |
Why?
|
Frontal Lobe | 1 | 2014 | 1407 | 0.080 |
Why?
|
Child, Preschool | 10 | 2023 | 40992 | 0.080 |
Why?
|
Carcinoma, Embryonal | 1 | 2007 | 38 | 0.080 |
Why?
|
Receptors, Androgen | 1 | 2014 | 1057 | 0.080 |
Why?
|
Salvage Therapy | 1 | 2014 | 1275 | 0.080 |
Why?
|
High-Throughput Screening Assays | 1 | 2013 | 945 | 0.070 |
Why?
|
Mice, Nude | 3 | 2020 | 3689 | 0.070 |
Why?
|
Skin Neoplasms | 2 | 2022 | 5670 | 0.070 |
Why?
|
Blotting, Western | 1 | 2015 | 5180 | 0.070 |
Why?
|
Peptides, Cyclic | 1 | 2009 | 401 | 0.070 |
Why?
|
Oxidative Stress | 3 | 2019 | 3085 | 0.070 |
Why?
|
Hydrogen Peroxide | 1 | 2010 | 731 | 0.070 |
Why?
|
Receptors, Antigen, T-Cell | 3 | 2021 | 2540 | 0.070 |
Why?
|
World Health Organization | 2 | 2023 | 1318 | 0.070 |
Why?
|
Cyclin-Dependent Kinase 4 | 2 | 2021 | 535 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3646 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 2016 | 1903 | 0.070 |
Why?
|
Temporal Lobe | 1 | 2014 | 1670 | 0.070 |
Why?
|
Pyridines | 2 | 2021 | 2822 | 0.070 |
Why?
|
Reproducibility of Results | 8 | 2022 | 19907 | 0.070 |
Why?
|
Parkinsonian Disorders | 1 | 2009 | 275 | 0.070 |
Why?
|
Cell Cycle Proteins | 2 | 2019 | 3461 | 0.070 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2014 | 1509 | 0.070 |
Why?
|
Mycosis Fungoides | 1 | 2007 | 163 | 0.070 |
Why?
|
Seminoma | 1 | 2007 | 136 | 0.070 |
Why?
|
Radiography | 2 | 2014 | 7022 | 0.070 |
Why?
|
Ear Canal | 1 | 2006 | 146 | 0.070 |
Why?
|
Active Transport, Cell Nucleus | 2 | 2012 | 443 | 0.070 |
Why?
|
Mutation, Missense | 2 | 2014 | 2563 | 0.070 |
Why?
|
NF-E2-Related Factor 2 | 2 | 2024 | 377 | 0.070 |
Why?
|
Antigen Presentation | 2 | 2023 | 1284 | 0.070 |
Why?
|
Dacarbazine | 1 | 2009 | 567 | 0.070 |
Why?
|
Virus Replication | 1 | 2014 | 2534 | 0.070 |
Why?
|
Receptors, Estrogen | 1 | 2014 | 2186 | 0.070 |
Why?
|
Transcription, Genetic | 1 | 2020 | 7723 | 0.070 |
Why?
|
DNA, Neoplasm | 1 | 2011 | 1758 | 0.070 |
Why?
|
Neurosurgical Procedures | 1 | 2016 | 2003 | 0.070 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2013 | 1221 | 0.060 |
Why?
|
Combined Modality Therapy | 4 | 2023 | 8628 | 0.060 |
Why?
|
Carrier Proteins | 1 | 1998 | 5021 | 0.060 |
Why?
|
Imaging, Three-Dimensional | 2 | 2015 | 4044 | 0.060 |
Why?
|
Brain Stem Neoplasms | 1 | 2006 | 204 | 0.060 |
Why?
|
Prostatic Intraepithelial Neoplasia | 1 | 2004 | 76 | 0.060 |
Why?
|
Hematopoiesis | 1 | 2014 | 2069 | 0.060 |
Why?
|
Polymerase Chain Reaction | 2 | 2011 | 6172 | 0.060 |
Why?
|
Hematologic Neoplasms | 1 | 2016 | 1831 | 0.060 |
Why?
|
Infant | 8 | 2023 | 35129 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2020 | 21752 | 0.060 |
Why?
|
Sensitivity and Specificity | 5 | 2013 | 14726 | 0.060 |
Why?
|
Gene Expression Regulation | 3 | 2014 | 12075 | 0.060 |
Why?
|
DNA Modification Methylases | 2 | 2018 | 206 | 0.060 |
Why?
|
Alleles | 4 | 2018 | 6938 | 0.060 |
Why?
|
Neuroprotective Agents | 1 | 2010 | 941 | 0.060 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2007 | 336 | 0.060 |
Why?
|
DNA Methylation | 4 | 2023 | 4289 | 0.060 |
Why?
|
Gene Expression | 1 | 2016 | 7799 | 0.060 |
Why?
|
Alkaline Phosphatase | 1 | 2006 | 865 | 0.060 |
Why?
|
ARNTL Transcription Factors | 1 | 2024 | 98 | 0.060 |
Why?
|
Antigens, CD | 1 | 2014 | 4026 | 0.060 |
Why?
|
Craniotomy | 2 | 2019 | 729 | 0.060 |
Why?
|
alpha-Synuclein | 1 | 2009 | 725 | 0.060 |
Why?
|
Colorectal Neoplasms | 1 | 2023 | 6773 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2019 | 987 | 0.050 |
Why?
|
Astrocytes | 1 | 2010 | 1270 | 0.050 |
Why?
|
Pyrazoles | 1 | 2013 | 1973 | 0.050 |
Why?
|
Lymphocytes | 2 | 2001 | 2617 | 0.050 |
Why?
|
Dihydrolipoyllysine-Residue Acetyltransferase | 1 | 2022 | 11 | 0.050 |
Why?
|
DNA Repair Enzymes | 2 | 2018 | 349 | 0.050 |
Why?
|
Tissue Distribution | 2 | 2019 | 2335 | 0.050 |
Why?
|
Stem Cell Transplantation | 1 | 2011 | 1620 | 0.050 |
Why?
|
Microdissection | 1 | 2022 | 152 | 0.050 |
Why?
|
Gene Frequency | 2 | 2020 | 3588 | 0.050 |
Why?
|
Antibody Specificity | 1 | 2004 | 1095 | 0.050 |
Why?
|
Ionophores | 1 | 2022 | 108 | 0.050 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2020 | 2948 | 0.050 |
Why?
|
Research Design | 1 | 2018 | 5987 | 0.050 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 1 | 2022 | 182 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2021 | 2915 | 0.050 |
Why?
|
Hepatolenticular Degeneration | 1 | 2022 | 69 | 0.050 |
Why?
|
Energy Metabolism | 1 | 2013 | 2895 | 0.050 |
Why?
|
Equilibrative Nucleoside Transporter 1 | 1 | 2021 | 17 | 0.050 |
Why?
|
Multiple Myeloma | 1 | 2020 | 5180 | 0.050 |
Why?
|
Iron-Sulfur Proteins | 1 | 2022 | 82 | 0.050 |
Why?
|
Flavobacterium | 1 | 2001 | 20 | 0.050 |
Why?
|
Lipoylation | 1 | 2022 | 72 | 0.050 |
Why?
|
Immunophenotyping | 2 | 2024 | 1880 | 0.050 |
Why?
|
Phospholipase C beta | 1 | 2001 | 50 | 0.050 |
Why?
|
Prostatic Neoplasms | 1 | 2004 | 11074 | 0.050 |
Why?
|
Genetic Testing | 1 | 2014 | 3443 | 0.050 |
Why?
|
Cell Respiration | 1 | 2022 | 200 | 0.050 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2022 | 424 | 0.050 |
Why?
|
Receptor, Serotonin, 5-HT2C | 1 | 2001 | 44 | 0.050 |
Why?
|
Cell Membrane | 2 | 2021 | 3748 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 2 | 2001 | 3772 | 0.050 |
Why?
|
Receptors, CCR6 | 1 | 2021 | 81 | 0.050 |
Why?
|
Immunoglobulin Joining Region | 1 | 2001 | 36 | 0.050 |
Why?
|
Nuclear Localization Signals | 1 | 2001 | 80 | 0.050 |
Why?
|
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2021 | 38 | 0.050 |
Why?
|
Retrospective Studies | 6 | 2023 | 77426 | 0.050 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 1 | 2001 | 170 | 0.050 |
Why?
|
Receptors, Muscarinic | 1 | 2001 | 156 | 0.050 |
Why?
|
Testicular Neoplasms | 1 | 2007 | 761 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7281 | 0.050 |
Why?
|
Kinetics | 2 | 1999 | 6474 | 0.050 |
Why?
|
Calibration | 1 | 2023 | 816 | 0.050 |
Why?
|
Mammary Glands, Animal | 1 | 2022 | 277 | 0.050 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2001 | 140 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 2013 | 4553 | 0.050 |
Why?
|
Chemical Precipitation | 1 | 2000 | 180 | 0.050 |
Why?
|
Acrylonitrile | 1 | 2020 | 21 | 0.050 |
Why?
|
Cells, Cultured | 4 | 2019 | 19227 | 0.050 |
Why?
|
Pilot Projects | 3 | 2019 | 8321 | 0.050 |
Why?
|
Phosphatidylinositol Phosphates | 1 | 2001 | 209 | 0.050 |
Why?
|
Repetitive Sequences, Amino Acid | 1 | 2000 | 95 | 0.050 |
Why?
|
Hydrazines | 1 | 2022 | 226 | 0.050 |
Why?
|
Receptors, Serotonin | 1 | 2001 | 210 | 0.050 |
Why?
|
Caenorhabditis elegans | 1 | 2009 | 1420 | 0.050 |
Why?
|
Haplorhini | 1 | 2021 | 552 | 0.050 |
Why?
|
Membrane Lipids | 1 | 2001 | 248 | 0.050 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2019 | 3474 | 0.050 |
Why?
|
Cervical Vertebrae | 1 | 2006 | 975 | 0.050 |
Why?
|
Matrix Metalloproteinase 13 | 1 | 2020 | 103 | 0.040 |
Why?
|
Receptors, Antigen | 1 | 1999 | 53 | 0.040 |
Why?
|
Immunoglobulin Variable Region | 1 | 2001 | 421 | 0.040 |
Why?
|
Transposases | 1 | 1999 | 107 | 0.040 |
Why?
|
Calcium-Binding Proteins | 1 | 2004 | 1080 | 0.040 |
Why?
|
Reference Standards | 1 | 2023 | 1025 | 0.040 |
Why?
|
Endopeptidase Clp | 1 | 1999 | 47 | 0.040 |
Why?
|
Cyclin D2 | 1 | 2019 | 101 | 0.040 |
Why?
|
Cell Line, Transformed | 1 | 2000 | 898 | 0.040 |
Why?
|
Crystallography, X-Ray | 2 | 2001 | 2012 | 0.040 |
Why?
|
Models, Genetic | 1 | 2009 | 3494 | 0.040 |
Why?
|
Genome, Human | 3 | 2020 | 4420 | 0.040 |
Why?
|
Genome-Wide Association Study | 2 | 2015 | 12264 | 0.040 |
Why?
|
Pathology, Molecular | 1 | 2022 | 326 | 0.040 |
Why?
|
Sex Chromatin | 1 | 2018 | 20 | 0.040 |
Why?
|
High Mobility Group Proteins | 1 | 1999 | 187 | 0.040 |
Why?
|
Seizures | 2 | 2013 | 2859 | 0.040 |
Why?
|
Random Allocation | 1 | 2023 | 2427 | 0.040 |
Why?
|
PTEN Phosphohydrolase | 2 | 2015 | 1143 | 0.040 |
Why?
|
Amino Acid Motifs | 1 | 2021 | 936 | 0.040 |
Why?
|
Atlases as Topic | 1 | 2020 | 237 | 0.040 |
Why?
|
Genes, myc | 1 | 2020 | 399 | 0.040 |
Why?
|
RNA, Neoplasm | 2 | 2012 | 769 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2017 | 15525 | 0.040 |
Why?
|
Genes, BRCA2 | 1 | 2022 | 618 | 0.040 |
Why?
|
Indazoles | 1 | 2020 | 287 | 0.040 |
Why?
|
Oxygen | 1 | 2010 | 4187 | 0.040 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2020 | 337 | 0.040 |
Why?
|
Saccharomyces cerevisiae | 1 | 2009 | 2752 | 0.040 |
Why?
|
Integrases | 1 | 2001 | 533 | 0.040 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2009 | 3617 | 0.040 |
Why?
|
Protein Conformation | 3 | 2001 | 4012 | 0.040 |
Why?
|
Cluster Analysis | 2 | 2015 | 2715 | 0.040 |
Why?
|
Tryptophan | 1 | 2000 | 479 | 0.040 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2023 | 1157 | 0.040 |
Why?
|
S Phase | 1 | 2019 | 423 | 0.040 |
Why?
|
Zinc Fingers | 1 | 2000 | 585 | 0.040 |
Why?
|
Genes, Recessive | 1 | 2000 | 643 | 0.040 |
Why?
|
Genes, BRCA1 | 1 | 2022 | 781 | 0.040 |
Why?
|
Sequence Alignment | 2 | 1999 | 2256 | 0.040 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2007 | 1519 | 0.040 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 1999 | 374 | 0.040 |
Why?
|
Histone Demethylases | 1 | 2020 | 321 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2011 | 12244 | 0.040 |
Why?
|
Microsatellite Repeats | 1 | 2020 | 802 | 0.040 |
Why?
|
Remission Induction | 1 | 2023 | 2389 | 0.040 |
Why?
|
Mice, Inbred BALB C | 2 | 2020 | 6386 | 0.040 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2018 | 367 | 0.040 |
Why?
|
Prospective Studies | 3 | 2023 | 53280 | 0.040 |
Why?
|
Metabolic Networks and Pathways | 1 | 2022 | 782 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2020 | 704 | 0.040 |
Why?
|
Mitochondrial Proteins | 1 | 2023 | 996 | 0.040 |
Why?
|
Deoxycytidine | 1 | 2021 | 825 | 0.040 |
Why?
|
Isotretinoin | 1 | 2018 | 114 | 0.040 |
Why?
|
Drug Synergism | 1 | 2021 | 1791 | 0.040 |
Why?
|
Quinazolines | 2 | 2014 | 1356 | 0.040 |
Why?
|
Syndrome | 2 | 2000 | 3250 | 0.040 |
Why?
|
Mammals | 1 | 2022 | 1144 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2020 | 426 | 0.040 |
Why?
|
Conserved Sequence | 1 | 2000 | 1202 | 0.040 |
Why?
|
Endocytosis | 1 | 2021 | 985 | 0.040 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2000 | 1724 | 0.040 |
Why?
|
Japan | 1 | 2021 | 1361 | 0.040 |
Why?
|
Chromogranins | 1 | 2017 | 163 | 0.040 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2018 | 713 | 0.030 |
Why?
|
Lipopolysaccharides | 1 | 2024 | 2216 | 0.030 |
Why?
|
Etoposide | 1 | 2018 | 639 | 0.030 |
Why?
|
Interferons | 1 | 2020 | 706 | 0.030 |
Why?
|
Lysosomes | 1 | 2021 | 893 | 0.030 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2018 | 658 | 0.030 |
Why?
|
Luminescent Proteins | 1 | 1999 | 853 | 0.030 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2018 | 876 | 0.030 |
Why?
|
Structure-Activity Relationship | 2 | 2014 | 3133 | 0.030 |
Why?
|
Eye Proteins | 1 | 1999 | 646 | 0.030 |
Why?
|
Nucleic Acid Conformation | 1 | 1999 | 914 | 0.030 |
Why?
|
Mutagenesis | 1 | 2020 | 1267 | 0.030 |
Why?
|
Microfilament Proteins | 1 | 2021 | 1152 | 0.030 |
Why?
|
Gene Fusion | 1 | 2018 | 371 | 0.030 |
Why?
|
Testis | 1 | 1999 | 800 | 0.030 |
Why?
|
Vincristine | 1 | 2018 | 1036 | 0.030 |
Why?
|
Prostatectomy | 1 | 2004 | 1887 | 0.030 |
Why?
|
Macrophages | 2 | 2020 | 5657 | 0.030 |
Why?
|
Gene Amplification | 1 | 2020 | 1062 | 0.030 |
Why?
|
Manganese | 1 | 1998 | 408 | 0.030 |
Why?
|
Organoids | 1 | 2021 | 700 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2012 | 21824 | 0.030 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2017 | 202 | 0.030 |
Why?
|
Ovary | 1 | 2020 | 981 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2000 | 1792 | 0.030 |
Why?
|
INDEL Mutation | 1 | 2016 | 279 | 0.030 |
Why?
|
Aniline Compounds | 1 | 2020 | 986 | 0.030 |
Why?
|
Protein Processing, Post-Translational | 2 | 2014 | 1990 | 0.030 |
Why?
|
Central Nervous System | 1 | 2022 | 1357 | 0.030 |
Why?
|
Magnesium | 1 | 1998 | 813 | 0.030 |
Why?
|
Withania | 1 | 2014 | 3 | 0.030 |
Why?
|
Oleic Acid | 1 | 2014 | 85 | 0.030 |
Why?
|
Microinjections | 1 | 2015 | 327 | 0.030 |
Why?
|
Substrate Specificity | 2 | 2013 | 1801 | 0.030 |
Why?
|
Neurons | 2 | 2010 | 9335 | 0.030 |
Why?
|
Oximes | 1 | 2015 | 311 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2022 | 3203 | 0.030 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2014 | 323 | 0.030 |
Why?
|
Hematoxylin | 1 | 2013 | 64 | 0.030 |
Why?
|
Eosine Yellowish-(YS) | 1 | 2013 | 72 | 0.030 |
Why?
|
Serine Endopeptidases | 1 | 1999 | 1073 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2020 | 956 | 0.030 |
Why?
|
Skull Base | 1 | 2016 | 306 | 0.030 |
Why?
|
Recombinant Proteins | 2 | 2000 | 6612 | 0.030 |
Why?
|
Receptor, trkC | 1 | 2013 | 68 | 0.030 |
Why?
|
Green Fluorescent Proteins | 1 | 1999 | 2088 | 0.030 |
Why?
|
Prenatal Diagnosis | 1 | 2000 | 1236 | 0.030 |
Why?
|
Cloning, Molecular | 1 | 1999 | 4321 | 0.030 |
Why?
|
Pyrimidinones | 1 | 2015 | 371 | 0.030 |
Why?
|
Plasmalogens | 1 | 2013 | 30 | 0.030 |
Why?
|
Data Collection | 1 | 2022 | 3340 | 0.030 |
Why?
|
New Hampshire | 1 | 2013 | 172 | 0.030 |
Why?
|
United States | 2 | 2021 | 69867 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2019 | 1366 | 0.030 |
Why?
|
Leupeptins | 1 | 2012 | 122 | 0.030 |
Why?
|
Postoperative Period | 1 | 2018 | 1841 | 0.030 |
Why?
|
Sulfhydryl Compounds | 1 | 2014 | 297 | 0.030 |
Why?
|
Genetic Variation | 2 | 2015 | 6546 | 0.030 |
Why?
|
Escherichia coli Proteins | 1 | 1999 | 1053 | 0.030 |
Why?
|
Color | 1 | 2013 | 307 | 0.030 |
Why?
|
Phosphotransferases | 1 | 2013 | 308 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2013 | 318 | 0.030 |
Why?
|
Chemokine CXCL12 | 1 | 2014 | 464 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2015 | 940 | 0.030 |
Why?
|
Disulfides | 1 | 2014 | 457 | 0.030 |
Why?
|
Circadian Rhythm | 1 | 2024 | 2624 | 0.030 |
Why?
|
Protein Binding | 4 | 2013 | 9392 | 0.030 |
Why?
|
Neural Stem Cells | 1 | 2019 | 850 | 0.030 |
Why?
|
Cyclophosphamide | 1 | 2018 | 2236 | 0.030 |
Why?
|
Genetic Heterogeneity | 1 | 2015 | 733 | 0.030 |
Why?
|
Age of Onset | 1 | 2018 | 3270 | 0.030 |
Why?
|
Phosphatidylinositols | 1 | 2013 | 291 | 0.030 |
Why?
|
Neurologic Examination | 1 | 2015 | 931 | 0.030 |
Why?
|
Heme | 1 | 2013 | 307 | 0.030 |
Why?
|
Piperidines | 1 | 2020 | 1605 | 0.030 |
Why?
|
Phosphatidylserines | 1 | 2013 | 193 | 0.030 |
Why?
|
Administration, Oral | 1 | 2019 | 3913 | 0.020 |
Why?
|
Permeability | 1 | 2013 | 738 | 0.020 |
Why?
|
3T3 Cells | 1 | 2013 | 1101 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2015 | 1574 | 0.020 |
Why?
|
Macrolides | 1 | 2012 | 201 | 0.020 |
Why?
|
Superoxide Dismutase | 1 | 2014 | 596 | 0.020 |
Why?
|
Pregnancy | 3 | 2022 | 29142 | 0.020 |
Why?
|
Rhodotorula | 1 | 2010 | 1 | 0.020 |
Why?
|
Cerebellum | 1 | 2018 | 1490 | 0.020 |
Why?
|
Transfection | 1 | 1999 | 5892 | 0.020 |
Why?
|
Models, Biological | 2 | 2012 | 9582 | 0.020 |
Why?
|
Homeostasis | 1 | 2022 | 3339 | 0.020 |
Why?
|
D-Amino-Acid Oxidase | 1 | 2010 | 27 | 0.020 |
Why?
|
Pyridones | 1 | 2015 | 712 | 0.020 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2012 | 190 | 0.020 |
Why?
|
Neoplasm, Residual | 1 | 2015 | 972 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2020 | 4201 | 0.020 |
Why?
|
Stereotaxic Techniques | 1 | 2013 | 535 | 0.020 |
Why?
|
Lymph Nodes | 2 | 2015 | 3469 | 0.020 |
Why?
|
Immunoblotting | 1 | 2014 | 1682 | 0.020 |
Why?
|
Piperazines | 1 | 2021 | 2491 | 0.020 |
Why?
|
Specimen Handling | 1 | 2015 | 694 | 0.020 |
Why?
|
Freezing | 1 | 2011 | 303 | 0.020 |
Why?
|
Rats | 2 | 2021 | 24273 | 0.020 |
Why?
|
Down-Regulation | 1 | 2017 | 3001 | 0.020 |
Why?
|
Electrodiagnosis | 1 | 2010 | 154 | 0.020 |
Why?
|
Charcot-Marie-Tooth Disease | 1 | 2010 | 98 | 0.020 |
Why?
|
Infant, Newborn | 3 | 2020 | 25618 | 0.020 |
Why?
|
Risk Assessment | 2 | 2023 | 23337 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2014 | 1877 | 0.020 |
Why?
|
Multigene Family | 1 | 2013 | 1102 | 0.020 |
Why?
|
Molecular Structure | 1 | 2014 | 1907 | 0.020 |
Why?
|
Autophagy | 1 | 2017 | 1300 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2019 | 2416 | 0.020 |
Why?
|
Imidazoles | 1 | 2015 | 1206 | 0.020 |
Why?
|
Vaccination | 1 | 2021 | 3278 | 0.020 |
Why?
|
Peptides | 1 | 2021 | 4407 | 0.020 |
Why?
|
Neural Conduction | 1 | 2010 | 468 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2022 | 4385 | 0.020 |
Why?
|
DNA Helicases | 1 | 2014 | 861 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2015 | 1157 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2018 | 1582 | 0.020 |
Why?
|
Mice, SCID | 1 | 2014 | 2716 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2019 | 2726 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2017 | 2108 | 0.020 |
Why?
|
Gene Silencing | 1 | 2014 | 1538 | 0.020 |
Why?
|
Karyotyping | 1 | 2010 | 1243 | 0.020 |
Why?
|
Glutathione | 1 | 2010 | 588 | 0.020 |
Why?
|
Codon | 1 | 2009 | 611 | 0.020 |
Why?
|
Brain | 4 | 2019 | 26413 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2012 | 1655 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2000 | 5096 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2004 | 7879 | 0.020 |
Why?
|
Collagen | 1 | 2016 | 2689 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2010 | 766 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2000 | 4665 | 0.020 |
Why?
|
Observer Variation | 1 | 2013 | 2593 | 0.020 |
Why?
|
Cytokines | 1 | 2022 | 7326 | 0.020 |
Why?
|
Drug Design | 1 | 2012 | 1078 | 0.020 |
Why?
|
Equipment Design | 1 | 2015 | 3582 | 0.020 |
Why?
|
Drug Approval | 1 | 2013 | 741 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2014 | 15070 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2010 | 1341 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10396 | 0.020 |
Why?
|
Organ Specificity | 1 | 2011 | 2007 | 0.020 |
Why?
|
Hot Temperature | 1 | 2012 | 1355 | 0.020 |
Why?
|
Fatty Acids | 1 | 2014 | 1808 | 0.020 |
Why?
|
Loss of Heterozygosity | 1 | 2009 | 684 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2014 | 2008 | 0.020 |
Why?
|
Sirolimus | 1 | 2014 | 1563 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3921 | 0.020 |
Why?
|
Mastectomy | 1 | 2014 | 1793 | 0.020 |
Why?
|
Biopsy | 1 | 2017 | 6757 | 0.020 |
Why?
|
Protein Folding | 1 | 2009 | 843 | 0.020 |
Why?
|
Artifacts | 1 | 2014 | 1903 | 0.020 |
Why?
|
Fever | 1 | 2013 | 1614 | 0.020 |
Why?
|
DNA Primers | 1 | 2009 | 2892 | 0.020 |
Why?
|
Headache | 1 | 2013 | 1226 | 0.020 |
Why?
|
Computational Biology | 1 | 2016 | 3523 | 0.020 |
Why?
|
Fibroblasts | 1 | 2014 | 4156 | 0.010 |
Why?
|
Gene Regulatory Networks | 1 | 2012 | 1708 | 0.010 |
Why?
|
Liver | 1 | 1999 | 7472 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2012 | 3505 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2013 | 2636 | 0.010 |
Why?
|
Pluripotent Stem Cells | 1 | 2010 | 795 | 0.010 |
Why?
|
Recurrence | 1 | 2014 | 8343 | 0.010 |
Why?
|
Quality of Life | 1 | 2024 | 12805 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2017 | 6274 | 0.010 |
Why?
|
Bone Neoplasms | 1 | 2014 | 2525 | 0.010 |
Why?
|
Binding Sites | 2 | 2001 | 6116 | 0.010 |
Why?
|
Cations, Divalent | 1 | 2001 | 166 | 0.010 |
Why?
|
Ultracentrifugation | 1 | 2001 | 182 | 0.010 |
Why?
|
Recombinases | 1 | 2001 | 67 | 0.010 |
Why?
|
Chromatography, Gel | 1 | 2001 | 668 | 0.010 |
Why?
|
Models, Molecular | 2 | 2001 | 5458 | 0.010 |
Why?
|
Massachusetts | 1 | 2013 | 8663 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2014 | 12355 | 0.010 |
Why?
|
Catalysis | 1 | 2001 | 761 | 0.010 |
Why?
|
Dimerization | 1 | 2001 | 893 | 0.010 |
Why?
|
Length of Stay | 1 | 2013 | 6308 | 0.010 |
Why?
|
Scattering, Radiation | 1 | 2001 | 498 | 0.010 |
Why?
|
Molecular Weight | 1 | 2001 | 2255 | 0.010 |
Why?
|
Models, Statistical | 1 | 2013 | 5102 | 0.010 |
Why?
|
Maternal-Fetal Exchange | 1 | 2001 | 455 | 0.010 |
Why?
|
Lymphopenia | 1 | 2001 | 285 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2009 | 6893 | 0.010 |
Why?
|
Clonal Anergy | 1 | 1998 | 169 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 2014 | 5709 | 0.010 |
Why?
|
Risk Factors | 1 | 2023 | 72280 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 1999 | 1246 | 0.010 |
Why?
|
Family Health | 1 | 2001 | 1282 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2001 | 3701 | 0.010 |
Why?
|
Light | 1 | 2001 | 1374 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2013 | 18027 | 0.010 |
Why?
|
Alternative Splicing | 1 | 1999 | 1118 | 0.010 |
Why?
|
Eosinophilia | 1 | 1998 | 542 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 1999 | 1782 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2015 | 15294 | 0.010 |
Why?
|
Calcium | 1 | 2001 | 5757 | 0.000 |
Why?
|
Lymphocyte Activation | 1 | 1998 | 5523 | 0.000 |
Why?
|
Databases, Factual | 1 | 2001 | 7730 | 0.000 |
Why?
|